Skip to main content

The Right Test, The First Time


Simple, fast and comprehensive, BIOFIRE® syndromic testing solutions deliver accurate results. The right test, the first time impacts all areas of patient care and improves antibiotic stewardship.

The BIOFIRE® Offer

Healthcare professionals often use slow, complicated, incomplete, and unreliable tests to identify pathogens of infectious diseases and accompanying antimicrobial resistance genes, resulting in suboptimal patient treatment and management. 

Leading the industry in PCR testing for infectious diseases, BIOFIRE syndromic testing solutions provide healthcare professionals rapid, easy-to-use, and comprehensive PCR tests across a wide range of syndromes that yield accurate and actionable results in ~15 minutes to ~1 hour. 

It is important to choose the right test the first time, especially when it comes to top-of-mind threats like antibiotic resistance, sepsis, and COVID-19. BIOFIRE solutions provide the rapid answers you can rely on, helping to relieve anxious patients and optimize therapy faster. Testing early with BIOFIRE solutions has demonstrated improved patient outcomes, optimized patient management, better antimicrobial stewardship, cumulative cost and time-savings realized throughout the entire patient journey.

Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

Our automated, user-friendly platform requires just two minutes of hands-on time, optimizing laboratory productivity with automated, around-the-clock diagnostic testing. Features include scalable design, simplified workflow, and LIS-interfacing capabilities. 

Our latest advancement in syndromic infectious disease diagnostics, SPOTFIRE® is specifically designed for point-of-care testing. All our expertise and cutting-edge FILMARRAY® technology is at the heart of the system design. 


    This Changes Everything.

    SPOTFIRE® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux. All our expertise and cutting-edge FILMARRAY® technology is at the heart of the system design.

    SPOTFIRE® offers a multiplex PCR solution for Point-of-care testing, offering rapid and actionable results onsite. It can run syndromic test on 1,2,3 or 4 modules and automates molecular results in minutes.

Our revolutionary BIOFIRE® SPOTFIRE® Panel portfolio of versatile, respiratory PCR tests give clinicians targeted and syndromic options as they care for a variety of patients.

The BIOFIRE® FILMARRAY® Panel portfolio includes six syndromic panels providing pathogen-specific results in about an hour. With over 170 targets, the BIOFIRE® FILMARRAY® Panel portfolio offers the largest infectious disease menu on the market.

  • BIOFIRE® Respiratory 2.1 and 2.1plus Panels

    1 Test. Up to 23 Targets. ~45 Minutes.

    The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

  • BIOFIRE® Blood Culture Identification 2 Panel

    1 Test. 43 Targets. ~1 Hour.

    The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

  • BIOFIRE® FILMARRAY® Gastrointestinal Panel

    1 Test. 22 Targets. ~1 Hour.

    This alternative method to traditional stool testing is fast, sensitive, and comprehensive with a panel menu that includes bacteria, viruses, and parasites, causing infectious gastroenteritis.

  • BIOFIRE® FILMARRAY® Meningitis/Encephalitis Panel

    1 Test. 14 Targets. ~1 Hour.

    The BIOFIRE ME Panel provides answers on 14 of the most common bacterial, viral, and yeast pathogens that cause central nervous system infections to help healthcare providers rapidly distinguish between bacterial and viral meningitis and optimize life-saving therapy. 

  • BIOFIRE® FILMARRAY® Pneumonia & Pneumonia plus Panels

    1 Test. Up to 34 Targets. ~1 Hour.

    Syndromic tests targeting a comprehensive menu of bacteria and viruses that cause pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.

  • BIOFIRE® Joint Infection (JI) Panel

    1 Test. 39 Targets. ~1 Hour.

    Using PCR technology, the BIOFIRE JI Panel is a rapid syndromic test that delivers comprehensive results in one easy-to-read report.

Providing a comprehensive suite of software solutions that collect, analyze, and manage various sources of BIOFIRE® Systems data to empower your institution’s decision makers.


    Optimize Diagnostics With Data-driven Solutions.

    Providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more. 

  • BIOFIRE® Syndromic Trends

    Turn BIOFIRE® System Results into Smart Pathogen Trending

    Creating a global surveillance network that displays BIOFIRE® Panel test results from participating laboratories and hospitals around the world, BIOFIRE TREND allows users to explore epidemiology insights and better understand site-specific and regional pathogen trends and seasonality. 

Useful Resources on BIOFIRE® SOLUTIONS

BIOFIRE® Sales Brochure - plus version

BIOFIRE® Sales Brochure

BIOFIRE® All Panels Information Sheet - plus version

BIOFIRE® All Panels Information Sheet

BIOFIRE® Pediatricians Brochure - plus version

BIOFIRE® Pediatricians Brochure

BIOFIRE® Critical Care Brochure - plus version

BIOFIRE® Critical Care Brochure


BIOFIRE® SPOTFIRE® Respiratory (R) Panel Info Sheet

BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini Info Sheet

BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Info Sheet


Contact Us for Information on BIOFIRE® SOLUTIONS

Contact Us